defensin
effector
compon
innat
immun
system
broad
antimicrobi
activ
human
express
two
type
defensin
antivir
activ
envelop
nonenvelop
virus
divers
defensinsensit
viral
speci
reflect
multitud
antivir
mechan
includ
direct
defensin
target
viral
envelop
glycoprotein
capsid
addit
inhibit
viral
fusion
postentri
neutral
bind
modul
host
cell
surfac
receptor
disrupt
intracellular
signal
defensin
also
inhibit
viral
replic
addit
defensin
function
chemokin
augment
alter
adapt
immun
respons
reveal
indirect
antivir
mechan
nonetheless
mani
question
regard
antivir
activ
defensin
remain
although
signific
mechanist
data
known
molecular
detail
inhibit
mostli
lack
importantli
role
defensin
antivir
activ
vivo
address
due
lack
complet
defensin
knockout
model
overal
antivir
activ
defensin
well
establish
varieti
mechan
defensin
achiev
inhibit
howev
addit
research
need
fulli
understand
role
defensin
viral
pathogenesi
defensin
one
abund
class
antimicrobi
peptid
human
primarili
studi
effector
compon
innat
immun
respons
direct
antibacteri
activ
howev
antivir
properti
appreci
earliest
function
studi
fact
abil
neutral
herp
simplex
viru
one
defin
criteria
identif
purif
human
neutrophil
peptid
human
neutrophil
review
summar
known
activ
virus
refer
reader
addit
recent
review
topic
insight
focu
primarili
human
defensin
hd
organ
discuss
mechan
fig
emphas
common
antivir
activ
defensin
divers
viral
famili
structur
evolut
tissu
distribut
defensin
summar
number
recent
review
briefli
defensin
small
amino
acid
cation
amphipath
peptid
predominantli
structur
stabil
three
disulfid
bond
broadli
classifi
basi
structur
disulfid
bond
organ
three
group
human
lack
discuss
detail
howev
antivir
properti
recent
review
human
express
subdivid
myeloid
enter
peptid
basi
express
pattern
genet
organ
shown
multimer
least
dimer
either
solut
crystal
structur
predominantli
express
neutrophil
also
found
express
monocytemacrophag
natur
killer
cell
cell
b
cell
immatur
dendrit
cell
dc
express
special
epitheli
paneth
cell
small
intestin
also
express
epitheli
cell
male
femal
genitourinari
tract
human
hbd
wide
express
epitheli
cell
skin
mucos
surfac
contact
environ
like
eg
exist
oligomer
form
other
monomer
also
express
monocyt
macrophag
certain
dc
subset
express
male
reproduct
tract
although
common
express
pattern
defensin
human
speci
one
import
differ
relev
experiment
model
infecti
diseas
mice
lack
myeloid
quantif
physiolog
defensin
concentr
vivo
complex
defensin
present
high
local
concentr
within
specif
cell
type
upon
releas
cell
confin
anatom
nich
eg
crypt
small
intestin
becom
dilut
extracellular
fluid
myeloid
daher
et
al
mm
mgml
hnp
neutrophil
even
higher
local
concentr
azurophil
granul
store
enter
ayab
et
al
estim
concentr
mm
mgml
crypt
lumen
site
paneth
cell
degranul
concentr
like
similar
human
small
intestin
express
exce
healthi
patient
epitheli
line
fluid
lung
contain
nm
nasal
fluid
saliva
contain
vagin
secret
hnp
nm
measur
nasal
fluid
howev
certain
diseas
state
defensin
level
highli
elev
exampl
mm
concentr
found
epitheli
line
fluid
cystic
fibrosi
patient
overal
concentr
defensin
present
vivo
gener
within
rang
need
direct
antivir
activ
gener
major
antivir
mechan
defensin
defensin
inhibit
mani
step
envelop
nonenvelop
viral
infect
mechanist
inform
avail
rsv
hpiv
hiv
hsv
iav
bkv
hadv
hpv
mechan
impact
viral
entri
postentri
effect
describ
omit
defensin
effect
report
contribut
block
infect
doubt
eg
aggreg
hadv
note
although
defensin
relev
viru
step
indic
broad
classif
eg
case
defensin
within
group
test
equival
activ
concentr
requir
direct
antivir
activ
mode
determin
defensin
bind
virus
multipl
mode
defensin
bind
ligand
viral
particl
first
defensin
interact
lipid
bilay
facilit
presenc
neg
charg
phospholipid
second
four
lectin
capabl
bind
glycoprotein
glycolipid
third
defensin
potenti
engag
proteinprotein
proteindna
interact
cation
amphipath
defensin
interact
ligand
chargecharg
hydrophob
interact
defensin
oligomer
particularli
conform
stabil
impart
disulfid
bond
may
influenc
bind
interact
contribut
antivir
activ
defensin
rel
import
depend
specif
virusdefensin
pair
investig
properti
defensin
wide
investig
contribut
antivir
activ
stabil
threedimension
structur
fold
format
disulfid
bond
gener
destabil
linear
defensin
gener
substitut
conserv
cystein
residu
either
toto
individu
pair
natur
nonnatur
residu
form
disulfid
bond
serin
acid
altern
wildtyp
defensin
reduc
chemic
modifi
alkyl
prevent
disulfid
bond
format
report
studi
shown
disulfidestabil
form
requir
either
inhibit
human
adenoviru
hadv
serotyp
influenza
viru
iav
human
immunodefici
enhanc
viru
infect
two
case
antivir
activ
unaffect
linear
given
pauciti
data
regard
unclear
fundament
differ
antivir
activ
togeth
studi
suggest
effect
viru
infect
like
due
amphipath
abil
multimer
structur
depend
rather
net
posit
charg
molecul
common
nativ
linear
form
capac
defensin
function
lectin
bind
select
sugar
contribut
antivir
properti
howev
defensin
also
bind
host
cellular
serum
protein
rel
affin
viral
target
versu
serum
compon
may
explain
defensin
antivir
particular
virus
absenc
serum
although
shown
bind
natur
viral
glycoprotein
notabl
glycoprotein
gd
higher
affin
bovin
serum
albumin
fetuin
serum
substanti
attenu
antivir
activ
even
low
concentr
nonetheless
effect
overcom
higher
concentr
preincub
viru
ad
cell
addit
serum
also
abrog
antivir
activ
tropic
serum
also
compet
bind
inhibit
hadv
lack
viral
glycoprotein
two
notabl
except
abrog
effect
serum
inhibit
human
papillomaviru
hpv
human
bk
viru
bkv
infect
block
serum
respect
effect
serum
modul
infect
complic
cytotox
primari
cell
thu
applic
preincub
presenc
absenc
low
serum
primari
cell
result
enhanc
infect
cell
subsequ
cultur
standard
condit
fetal
bovin
serum
result
cell
death
cell
maintain
serumdepriv
condit
previous
found
proapoptot
primari
cell
absenc
serum
concentr
low
contrast
serum
condit
enhanc
infect
hela
cell
express
noncytotox
rapid
inactiv
bind
serum
compon
may
protect
host
cell
damag
defensin
howev
defensin
like
remain
potent
antivir
vivo
high
local
concentr
upon
initi
secret
serumfre
anatom
locat
eg
phagocyt
vacuol
bowel
lumen
although
much
antibacteri
activ
defensin
attenu
physiolog
salt
concentr
gener
true
antivir
activ
one
instanc
salt
sensit
attenu
antihiv
activ
physiolog
salt
concentr
somewhat
surpris
given
even
antibacteri
effect
gener
salt
sensit
nonetheless
antihiv
activ
lowsalt
serumfre
condit
may
reflect
physiolog
condit
oral
caviti
shown
superphysiolog
concentr
salt
inhibit
bind
hadv
implic
chargecharg
interact
bind
viral
capsid
gener
differenti
salt
sensit
may
reflect
variat
molecular
interact
mechan
defensinmedi
kill
neutral
virus
versu
bacteria
limit
number
structurefunct
studi
evalu
role
addit
featur
modul
viral
infect
shown
conserv
salt
bridg
stabil
loop
two
dispens
inhibit
similarli
mutat
invari
glycin
residu
glutam
sever
attenu
antibacteri
activ
result
minor
loss
antivir
activ
contrast
specif
arginin
residu
critic
bind
activ
pure
charg
depend
lysin
substitut
select
arginin
residu
preserv
antivir
activ
likewis
singl
arginin
mutat
attenu
enhanc
infect
indic
properti
also
simpli
charg
depend
furthermor
capac
selfassoci
critic
antivir
activ
gd
bind
properti
reveal
mutat
disrupt
defensin
activ
convers
approach
residu
posit
select
mutat
effort
augment
antivir
activ
one
mutant
demonstr
improv
activ
cell
cultur
prophylact
h
infect
therapeut
h
infect
protect
lethal
challeng
mous
model
collect
studi
suggest
specif
featur
virus
select
bound
defensin
bind
interfac
defensin
sequenc
specif
mere
charg
depend
basi
select
recognit
divers
virus
defensin
larg
unknown
defensin
may
interact
either
lipid
bilay
envelop
glycoprotein
envelop
virus
howev
proteinprotein
interact
must
critic
bind
nonenvelop
virus
eg
hpv
hadv
like
contribut
bind
envelop
virus
well
competit
sitespecif
antibodi
use
map
bind
site
speci
c
hadv
hadvc
use
structur
studi
chimer
approach
identifi
capsid
determin
bind
two
virus
almost
noth
known
specif
determin
viral
particl
dictat
defensin
bind
nonetheless
fact
close
relat
defensin
differenti
antivir
infectionenhanc
effect
indic
select
may
inform
design
futur
studi
elucid
basi
recognit
regard
tabl
summar
known
effect
defensin
viru
infect
includ
defensin
test
found
antivir
specif
virus
direct
interact
defensin
structur
compon
virion
particularli
lipid
bilay
envelop
virus
could
destroy
destabil
viru
render
noninfecti
mechan
propos
first
studi
antivir
activ
human
rabbit
neutrophil
support
hypothesi
inactiv
rabbit
impair
temperatur
effect
implic
fluiditi
membran
rather
bind
import
paramet
also
shown
bind
directli
model
membran
contain
phosphatidylserin
nonetheless
morpholog
electron
microscopi
alter
incub
neutral
concentr
bind
directli
inactiv
whether
interact
affect
damag
viral
envelop
unknown
similarli
treatment
absenc
serum
irrevers
decreas
infect
although
physic
chang
particl
integr
determin
recent
lipid
bilay
respiratori
syncyti
viru
rsv
expos
neutral
nonneutr
visibl
damag
assess
electron
microscopi
although
univers
phenotyp
quantifi
protein
bulk
popul
viru
buoyant
densiti
gradient
suggest
viral
particl
disrupt
alter
morpholog
correl
reduct
viru
attach
cell
perhap
convinc
data
direct
viral
envelop
disrupt
defensin
like
extend
human
parainfluenza
viru
profil
defensin
sensit
similar
rsv
broad
neutral
mani
envelop
virus
support
hypothesi
lipid
bilay
target
howev
envelop
virus
univers
suscept
sensit
highli
variabl
exampl
one
studi
rabbit
inhibit
vesicular
stomat
viru
vsv
iav
effect
cytomegaloviru
cmv
similarli
potent
inhibit
weakli
inhibit
cmv
vsv
iav
defensin
perturb
lipid
bilay
depend
upon
composit
favor
neg
charg
phospholipid
wherea
neutral
bilay
larg
inert
defensin
lipid
content
viral
envelop
depend
upon
subcellular
locat
membran
microdomain
bud
like
vari
among
viral
famili
direct
membran
perturb
contribut
antivir
effect
defensin
differ
lipid
composit
envelop
may
part
explain
differenti
suscept
virus
defensin
contrast
disrupt
envelop
virus
increas
capsid
resist
mechan
forc
heat
observ
upon
bind
nonenvelop
hadvc
effect
correl
inabl
particl
uncoat
similar
genet
mutant
hadvc
stabil
presenc
unprocess
precursor
capsid
protein
failur
uncoat
preclud
releas
intern
membranepermeabil
capsid
protein
therebi
block
hadvc
escap
endosom
introduct
viral
genom
nucleu
replic
nich
thu
unlik
envelop
virus
destabil
virion
impair
infect
opposit
stabil
interact
nonenvelop
hadvc
capsid
produc
similar
outcom
mani
defensin
form
multimer
structur
demonstr
crystal
structur
solut
potenti
interact
defensin
peptid
bound
neighbor
virus
caus
virion
aggreg
shown
directli
iav
bkv
iav
unclear
defensinmedi
aggreg
requir
block
infect
similarli
aggreg
hadv
suffici
inhibit
infect
nonneutr
mutant
abl
induc
aggreg
contrast
aggreg
concomit
inabl
bind
host
cell
shown
domin
mechan
neutral
bkv
mechan
inhibit
polyomavirus
jcv
also
sensit
determin
addit
multival
bind
due
defensin
oligomer
neutral
capsid
charg
defensin
bind
may
reduc
repuls
virion
shown
directli
hadvc
effect
may
facilit
aggreg
virus
effect
like
interrel
mutant
impair
selfassoci
incap
aggreg
hadvc
fulli
neutral
capsid
charg
aggreg
impact
viral
infect
directli
imped
cell
bind
caus
virus
clump
enter
fewer
cell
defensin
bind
viral
attach
protein
could
disrupt
receptor
interact
critic
viral
entri
cell
bind
recombin
viral
glycoprotein
gb
correl
abil
defensin
inhibit
entri
adhes
lectin
activ
critic
deglycosyl
gb
abrog
bind
contribut
glycoprotein
bind
antivir
mechan
underscor
direct
correl
capac
mutant
neutral
affin
recombin
gd
also
inhibit
infect
bind
viral
glycoprotein
instead
shown
bind
heparan
sulfat
receptor
attach
well
glycosaminoglycan
defensin
abl
bind
host
cell
receptor
viral
glycoprotein
defensin
fail
bind
gb
heparan
sulfat
also
unabl
neutral
infect
overal
block
host
cell
receptor
bind
viral
glycoprotein
major
mechan
defensin
inhibit
infect
similarli
bind
well
cell
surfac
receptor
bind
site
map
antibodi
competit
assay
coreceptor
bind
site
convers
bind
site
map
bind
site
mode
bind
may
complex
lectindepend
lectinindepend
bind
report
earli
studi
deglycosyl
reduc
bind
abolish
bind
howev
recent
paper
suggest
deglycosyl
affect
bind
addit
bind
abolish
deglycosyl
consist
observ
bind
weakli
polysaccharid
serum
protein
nonetheless
potent
inhibitor
summari
like
hsv
defensin
directli
interfer
bind
attach
contrast
block
cell
bind
observ
receptordepend
receptorindepend
bind
hadvc
cell
enhanc
presenc
inhibitori
concentr
effect
may
relat
neutral
net
neg
capsid
charg
promot
aggreg
manner
compar
enhanc
retroviru
infect
polybren
hadv
infect
polyc
similarli
bind
cell
infect
enhanc
thu
although
sever
case
net
effect
defensin
bind
viru
block
cellular
attach
opposit
effect
also
observ
balanc
activ
vivo
unclear
introduc
genom
host
cell
envelop
virus
must
fuse
lipid
bilay
host
cell
fusion
protein
viru
mediat
reaction
insert
hydrophob
stretch
amino
acid
target
cell
membran
follow
conform
chang
less
energet
state
term
sixhelix
bundl
energi
lipid
fusion
deriv
conform
chang
fusion
mediat
inhibit
inhibit
requir
disulfidestabil
form
abrog
serum
aggreg
recombin
peptid
carboxyland
aminotermini
compris
sixhelix
bundl
suggest
direct
effect
format
postfus
conform
also
increas
bind
efficaci
neutral
antibodi
specif
prehairpin
conform
like
due
greater
antibodi
access
hidden
neutral
epitop
consequ
slow
refold
kinet
thu
bind
directli
alter
fusion
interact
whether
mechan
neutral
extend
virus
shown
howev
differ
mechan
blockad
envelop
viru
fusion
due
host
cell
interact
discuss
antivir
mechan
target
cell
rather
fuse
cell
membran
nonenvelop
virus
must
penetr
limit
membran
host
cell
gener
mediat
specif
viral
protein
step
may
occur
plasma
membran
often
follow
conform
chang
lead
uncoat
viral
capsid
trigger
drop
ph
host
factor
endosom
pathway
hadv
intern
capsid
protein
vi
membran
lytic
factor
upon
bind
viral
capsid
includ
stabil
hadvc
prevent
uncoat
releas
protein
vi
subsequ
disrupt
endosom
membran
mediat
effect
bind
directli
viru
either
mix
togeth
absenc
cell
defensin
ad
viru
prebound
receptor
cell
surfac
thu
defensin
recogn
viru
complex
host
protein
carbohydr
lipid
could
potenti
compet
viru
defensin
bind
neutral
hadv
restrict
hadvb
hadvc
hadva
hadv
lesser
extent
wherea
hadvd
hadvf
infect
either
unaffect
enhanc
furthermor
resist
neutral
confer
hadvc
replac
capsid
vertex
protein
resist
hadvd
basi
enhanc
hadvd
infect
unknown
moreov
extent
antivir
mechan
hadvc
extend
nonenvelop
virus
determin
howev
entri
also
block
possibl
analog
step
infect
complet
mere
penetr
host
cell
membran
viral
transcript
protein
product
assembl
egress
must
occur
complet
replic
cycl
step
present
opportun
defensin
block
viral
infect
either
target
viru
specif
target
cell
regard
abl
block
ad
postentri
defensin
accumul
intracellularli
human
cervic
epitheli
cell
line
use
studi
indic
still
come
contact
virus
cell
hazrati
et
al
demonstr
bind
dna
specul
could
contribut
inhibit
block
gene
express
although
posttranscript
block
unknown
mechan
also
suggest
data
among
nonenvelop
virus
sensit
defensin
inhibit
step
penetr
cell
membran
thought
import
polyomavirus
hadv
multipl
type
papillomavirus
sensit
step
known
inhibit
nuclear
local
genom
last
step
viru
entri
pathway
unlik
case
hadvc
neutral
hpv
genom
expos
condit
neutral
impli
viru
uncoat
occur
presenc
defensin
thu
unclear
defensin
block
papillomaviru
penetr
host
membran
abil
genom
travers
cytoplasm
nucleu
lack
mechanist
insight
varieti
virus
shown
sensit
defensin
neutral
purifi
porcin
antivir
porcin
reproduct
respiratori
syndrom
viru
shown
reduc
yield
varicella
zoster
viru
day
postinfect
earlier
time
point
transduct
recombin
adenoassoci
viru
inhibit
rel
high
concentr
hnp
howev
hnp
measur
epitheli
line
fluid
cystic
fibrosi
patient
also
inhibitori
studi
moreov
vaccinia
viru
inhibit
incub
viru
h
whether
previous
describ
novel
mechan
contribut
neutral
virus
warrant
studi
addit
purifi
peptid
viru
inhibit
degranul
neutrophil
note
neutrophil
degranul
exampl
respons
stimul
leukotrien
releas
high
concentr
defensin
antimicrobi
factor
cmv
infect
human
peripher
blood
leukocyt
contain
neutrophil
weakli
inhibit
treatment
combin
human
cathelicidin
eosinophilderiv
neurotoxin
mediat
much
effect
cellfre
supernat
neutrophil
mix
cmv
similarli
inhibitori
antibodi
reduc
observ
activ
half
result
corrobor
data
modest
cmv
neutral
use
purifi
although
antivir
mechan
remain
unknown
studi
supernat
human
neutrophil
treat
stimul
synthes
strongli
inhibit
human
coronaviru
modestli
inhibit
rsv
influenza
b
viru
collect
studi
demonstr
natur
secret
defensin
retain
antivir
activ
contrast
shown
interact
reduc
activ
surfact
protein
bronchoalveolar
lavag
fluid
contain
surfact
protein
iav
observ
reinforc
import
studi
purifi
peptid
individu
biolog
effect
complex
mixtur
defensin
antimicrobi
factor
natur
produc
could
demonstr
synergist
altern
mutual
inhibitori
effect
rather
directli
target
viral
fusion
protein
block
envelop
viru
fusion
host
cell
synthet
human
call
retrocyclin
shown
inhibit
iav
fusion
crosslink
host
glycoprotein
retrocyclin
bind
limit
mobil
host
surfac
protein
vicin
nascent
viral
fusion
pore
restrict
matur
full
fusion
inhibit
block
serum
deglycosyl
pngase
treatment
cell
indic
effect
due
lectin
activ
defensin
regard
nondefensin
mannanbind
lectin
similar
effect
mechan
may
gener
inhibit
independ
direct
bind
viral
hemagglutinin
glycoprotein
extend
fusion
reaction
mediat
unrel
protein
baculoviru
sindbi
viru
recent
treatment
also
shown
decreas
mobil
fraction
receptor
cell
membran
reflect
phenomenon
mediat
lectin
activ
complex
entri
pathway
util
sever
cell
surfac
receptor
coreceptor
rel
abil
defensin
directli
modul
host
surfac
receptor
import
infect
debat
variou
group
peripher
blood
mononuclear
cell
pbmc
human
cell
line
express
reduc
cell
surfac
express
serum
subsequ
studi
confirm
downregul
pbmc
similar
condit
contrast
downmodul
observ
pbmc
treat
presenc
serum
similarli
primari
cell
presenc
serum
alter
express
cell
surfac
discrep
among
studi
like
explain
use
differ
cell
type
serum
concentr
experiment
condit
addit
effect
receptor
downregul
alway
correspond
broad
antivir
activ
defensin
multipl
isol
use
differ
coreceptor
thu
contribut
chang
cell
surfac
receptor
level
infect
remain
unresolv
mani
virus
regul
protein
kinas
c
pkc
signal
entri
infect
requir
phosphoryl
pkc
viral
fusion
transcript
integr
assembl
iav
requir
pkc
endosom
escap
nuclear
entri
hsv
requir
pkc
cell
entri
nuclear
egress
viral
capsid
known
inhibit
activ
pkc
vitro
alter
inhibit
cellular
signal
pathway
may
anoth
defensinmedi
antivir
mechan
explain
postentri
block
infect
observ
virus
treatment
cell
prior
infect
either
iav
reduc
level
phosphoryl
pkc
treatment
cell
pkc
activ
partial
rescu
infect
addit
pkc
inhibitor
similar
inhibit
kinet
inhibit
pkc
explain
observ
block
nuclear
import
incom
preintegr
complex
well
transcript
integr
viral
genom
cell
although
hsv
infect
also
inhibit
postentri
mechan
rescu
pretreat
addit
cellular
entri
hadv
serotyp
also
sensit
pkc
inhibit
howev
differenti
defensin
sensit
chimer
hadv
certain
capsid
protein
variabl
argu
role
cellular
target
pkc
hadv
neutral
togeth
data
indic
pkc
signal
pathway
involv
defensinmedi
neutral
hiv
possibl
iav
uninvolv
hsv
hadv
neutral
cell
signal
pathway
mediat
chemokin
receptor
also
play
role
defensinmedi
hiv
inhibit
known
bind
shown
induc
express
host
restrict
factor
apolipoprotein
b
mrnaedit
enzym
catalyt
polypeptidelik
antivir
activ
hiv
thu
defensin
inhibit
cellular
pathway
requir
viral
infect
activ
intracellular
antivir
mechan
addit
direct
antivir
properti
mani
defensin
function
cytokin
chemokin
elabor
antimicrobi
immun
respons
could
indirectli
affect
viral
pathogenesi
regard
number
virus
shown
stimul
defensin
express
secret
whether
elicit
defensin
directli
antivir
viru
primarili
observ
often
induc
express
rather
constitut
express
exampl
mrna
upregul
primari
bronchial
epitheli
cell
human
infect
subsequ
studi
confirm
mrna
upregul
demonstr
increas
protein
product
studi
found
viral
replic
requir
poli
c
singlestrand
rna
could
mimic
viral
infect
implic
requir
innat
intracellular
rna
detect
pathway
rigilik
receptor
consist
observ
multipl
hrv
serotyp
enter
via
distinct
receptor
pathway
similar
defensininduc
properti
despit
potent
upregul
direct
inactiv
observ
stimul
bronchial
epitheli
cell
synergist
induc
although
signal
pathway
lead
upregul
two
stimuli
partial
overlap
upregul
monitor
human
volunt
follow
experiment
infect
one
group
found
elev
messag
nasal
epitheli
scrape
protein
nasal
lavag
follow
lag
onset
symptom
howev
second
group
observ
low
level
increas
protein
sputum
day
postinfect
discrep
may
reflect
differ
patient
sampl
monitor
paramyxovirus
infect
neonat
lamb
ovin
parainfluenza
viru
elev
sheep
mrna
lung
compar
salin
control
caus
lower
respiratori
infect
lamb
similar
human
piv
children
express
distribut
similarli
increas
inflamm
infect
due
concurr
hadv
vector
infect
led
increas
express
contrast
bovin
rsv
infect
sheep
significantli
affect
express
thu
repair
regener
resolut
recoveri
inflamm
rather
acut
inflamm
due
viral
infect
may
associ
upregul
direct
antivir
activ
pathogen
assess
studi
rsv
infect
human
respiratori
epitheli
cell
messag
protein
upregul
manner
increas
express
result
induct
product
upon
rsv
infect
replic
pathway
may
relev
vivo
mice
challeng
intranas
rsv
express
increas
amount
murin
mbd
homolog
studi
elicit
also
shown
directli
antivir
disrupt
virion
integr
discuss
antivir
mechan
direct
interact
defensin
viru
addit
level
elev
tracheal
aspir
infant
infect
rsv
acut
ill
compar
convalesc
correct
total
phospholipid
content
sampl
author
suggest
increas
neutrophil
infiltr
alon
explain
elev
level
rather
increas
product
may
also
contribut
like
contribut
antirsv
activ
degranul
neutrophil
effect
purifi
hnp
rsv
address
either
studi
infect
epitheli
cell
transcript
upregul
neutral
block
infect
hacat
human
keratinocyt
vaccinia
viru
infect
shown
stimul
express
viru
sensit
infect
keratinocyt
induc
block
infect
furthermor
human
pbmc
plasmacytoid
dc
purifi
monocyt
increas
rna
protein
level
iav
sendai
viru
infect
uvinactiv
viru
less
stimulatori
indic
role
replic
similarli
iav
infect
mice
induc
express
nasosinu
trachea
lung
lung
overexpress
mdck
cell
addit
recombin
infect
inhibit
iav
infect
cell
cultur
summari
mani
studi
document
induct
defensin
express
consequ
viral
infect
induc
defensin
may
play
direct
indirect
role
viral
pathogenesi
work
demonstr
antivir
effect
defensin
cell
cultur
although
one
studi
show
increas
lethal
iav
infect
knockout
mous
result
attribut
increas
inflamm
knockout
mice
rather
direct
inhibit
viral
replic
similarli
administr
rhesu
protect
mice
lethal
sar
coronaviru
challeng
without
affect
lung
viral
titer
like
due
reduct
immunopatholog
treat
anim
fact
exampl
direct
role
endogen
defensin
block
viru
infect
vivo
larg
part
due
lack
complet
defensin
knockout
anim
model
indirect
evid
import
defensin
vivo
come
associ
studi
look
defensin
level
variou
viral
diseas
state
exampl
patient
atop
dermat
reduc
cathelicidin
greater
risk
develop
eczema
vaccinatum
transmiss
across
oral
epithelium
adult
rare
express
adult
fetal
oral
epitheli
cell
may
contribut
resist
inactiv
cross
epitheli
barrier
moreov
women
lower
level
lower
activ
cervicovagin
lavag
fluid
compar
healthi
control
similarli
cervicovagin
lavag
fluid
level
correl
activ
fluid
product
mrna
protein
monocytederiv
dc
higher
individu
compar
healthi
noninfect
control
moreov
cell
count
individu
higher
level
defensin
decreas
slowli
individu
lower
level
defensin
also
detect
breast
milk
mother
although
level
vari
approxim
nm
posit
correl
level
rna
howev
presenc
also
posit
correl
higher
matern
cell
count
decreas
risk
hiv
transmiss
breastfeed
mother
infant
appar
contradict
higher
level
correl
higher
hiv
viral
titer
yet
lower
transmiss
might
explain
fact
defensin
level
also
correl
healthier
matern
immun
system
indic
increas
cell
count
altern
infect
may
stimul
express
secret
thu
level
individu
correl
control
viral
infect
slow
diseas
progress
lower
vertic
transmiss
addit
evid
contribut
defensin
transmiss
diseas
progress
review
elsewher
addit
direct
antimicrobi
activ
defensin
abl
augment
direct
immun
respons
virus
way
impact
outcom
resolut
infect
myriad
mechan
defensin
immunomodulatori
review
elsewher
purpos
review
summar
activ
like
relev
viral
infect
neutrophil
enter
found
select
chemoattract
differ
subset
lymphocyt
macrophag
immatur
dc
although
chemokin
receptor
use
identifi
recruit
immun
cell
subset
site
viral
infect
undoubtedli
contribut
outcom
viral
infect
induc
chemotaxi
macrophag
also
induc
chemotaxi
immatur
dc
memori
cell
recruit
shown
occur
via
direct
bind
activ
chemokin
receptor
howev
conflict
paper
indic
although
induc
chemotaxi
macrophag
weakli
recruit
dc
addit
found
effect
independ
overal
abil
hbd
control
immun
cell
chemotaxi
therefor
regul
immun
respons
viral
infect
well
establish
even
remain
debat
specif
cell
subset
recruit
recruit
immun
cell
shown
relev
vivo
recombin
natur
produc
defensin
augment
adapt
immun
respons
intranas
inocul
mice
ovalbumin
ova
combin
result
increas
ovaspecif
igg
igm
titer
compar
mice
receiv
ova
alon
howev
despit
mucos
inocul
ovaspecif
iga
observ
indic
hnp
augment
may
allow
class
switch
subsequ
studi
coadminist
ova
intranas
individu
found
predomin
igg
isotyp
interleukin
profil
uniqu
defensin
use
highlight
complex
interact
defensin
immun
cell
final
augment
immun
respons
shown
function
relev
intraperiton
inject
hnp
enhanc
antibodi
respons
syngen
tumor
challeng
increas
surviv
time
mice
tumor
challeng
thu
although
yet
shown
context
infecti
challeng
stimul
adapt
immun
respons
defensin
like
contribut
antivir
immun
addit
induc
antibodi
secret
direct
contact
defensin
activ
immun
cell
induc
cytokin
secret
neutrophil
suppress
apoptosi
via
inhibit
caspas
could
help
prolong
immun
respons
also
shown
increas
neutrophil
uptak
iav
regard
dc
exposur
matur
activ
dc
direct
bind
activ
myeloid
dc
monocyt
via
also
activ
langerhan
celllik
dc
primari
human
cutan
dc
addit
promot
activ
matur
monocytederiv
dc
product
proinflammatori
cytokin
defensin
elicit
proinflammatori
cytokin
product
treat
cell
could
stimul
dc
moreov
also
shown
induc
ccchemokin
express
secret
macrophag
block
hiv
infect
therefor
activ
antigenexpress
cell
could
explain
indirect
mechan
also
increas
evid
defensin
immunosuppress
defensin
notabl
constitut
express
epitheli
surfac
specul
constitut
express
minim
effect
exposur
low
level
commens
pathogen
microb
allow
mainten
noninflammatori
environ
idea
support
fact
suppress
lipopolysaccharideinduc
product
proinflammatori
cytokin
human
mous
macrophag
worth
note
amount
use
studi
lower
amount
shown
activ
macrophag
via
tlr
neutral
infect
recent
natur
express
exogen
also
shown
reduc
innat
immun
respons
lentivir
vector
transduct
muscl
cell
final
line
previou
observ
cathelicidin
bind
dna
promot
uptak
plasmacytoid
dc
lead
interferon
product
overal
function
augment
alter
immun
respons
microb
respons
elicit
like
depend
upon
amount
microbi
stimuli
subsequ
concentr
defensin
produc
cell
cultur
shown
potent
antivir
wide
rang
viral
speci
howev
intrigu
differ
viral
neutral
one
begin
examin
interact
individu
defensin
virus
even
genu
identif
viral
determin
drive
differ
area
need
studi
appreci
inhibit
virus
numer
mechan
howev
mechanist
data
involv
mostli
lack
would
add
greatli
understand
defensin
impact
immun
respons
vivo
especi
true
induc
produc
epitheli
cell
respons
microbi
stimuli
therefor
could
provid
first
line
defens
mani
infect
virus
although
focus
antivir
mechan
enhanc
hadvd
hadv
hadvf
infect
defensin
observ
whether
enhanc
extend
virus
import
enhanc
infect
need
explor
final
vivo
relev
direct
defensin
kill
enhanc
unclear
lack
complet
defensin
knockout
model
hinder
studi
need
address
order
fulli
understand
role
defensin
viral
pathogenesi
great
interest
potenti
defensin
vaccin
adjuv
templat
design
novel
antivir
treatment
howev
applic
safe
efficaci
greater
understand
complex
role
defensin
viral
infect
need
